Franklin Resources Inc. Increases Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Franklin Resources Inc. raised its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 65.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 19,333 shares of the medical instruments supplier's stock after purchasing an additional 7,625 shares during the quarter. Franklin Resources Inc. owned 0.08% of ICU Medical worth $3,000,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ICUI. Harvest Fund Management Co. Ltd bought a new position in ICU Medical in the fourth quarter worth approximately $33,000. Murphy & Mullick Capital Management Corp purchased a new position in ICU Medical during the fourth quarter valued at $52,000. Venturi Wealth Management LLC grew its holdings in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the period. Smartleaf Asset Management LLC increased its position in ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after buying an additional 567 shares in the last quarter. Finally, OLD National Bancorp IN raised its stake in shares of ICU Medical by 22.0% in the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock worth $227,000 after buying an additional 264 shares during the period. Institutional investors own 96.10% of the company's stock.

ICU Medical Price Performance

ICU Medical stock traded down $0.47 during mid-day trading on Friday, reaching $138.67. 205,209 shares of the company's stock traded hands, compared to its average volume of 269,897. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock has a 50 day moving average of $146.73 and a two-hundred day moving average of $160.03. The company has a market cap of $3.40 billion, a price-to-earnings ratio of -30.34 and a beta of 0.86.

Analyst Ratings Changes

ICUI has been the topic of a number of research analyst reports. Raymond James set a $97.00 price target on ICU Medical in a report on Wednesday, March 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.